Correlation Between Cullinan Oncology and Xilio Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Xilio Development, you can compare the effects of market volatilities on Cullinan Oncology and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Xilio Development.

Diversification Opportunities for Cullinan Oncology and Xilio Development

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cullinan and Xilio is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Xilio Development go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Xilio Development

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.56 times more return on investment than Xilio Development. However, Cullinan Oncology LLC is 1.77 times less risky than Xilio Development. It trades about 0.02 of its potential returns per unit of risk. Xilio Development is currently generating about 0.01 per unit of risk. If you would invest  1,192  in Cullinan Oncology LLC on September 4, 2024 and sell it today you would earn a total of  125.00  from holding Cullinan Oncology LLC or generate 10.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  Xilio Development

 Performance 
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Xilio Development 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Xilio Development are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Xilio Development displayed solid returns over the last few months and may actually be approaching a breakup point.

Cullinan Oncology and Xilio Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cullinan Oncology and Xilio Development

The main advantage of trading using opposite Cullinan Oncology and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.
The idea behind Cullinan Oncology LLC and Xilio Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas